Stock Events

Stock Events

Search...

Regeneron Pharmaceuticals (REGN) Q1 2026 Earnings

30JanConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

8.22

9.78

11.33

12.89

Details

Expected EPS

10.735553

Actual EPS

11.44

Surprise EPS

0.7

Surprise Percent

+6.56%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 11.44 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.